Macrophages respond to infection with pathogenic Yersinia species by activating MAPK- and NF-κB-signaling pathways. To counteract this response, Yersiniae secrete a protease (Yersinia outer protein J (YopJ)) that is delivered into macrophages, deactivates MAPK- and NF-κB-signaling pathways, and induces apoptosis. NF-κB promotes cell survival by up-regulating expression of several apoptosis inhibitor genes. Previous studies show that deactivation of the NF-κB pathway by YopJ is important for Yersinia-induced apoptosis. To determine whether deactivation of the NF-κB pathway is sufficient for Yersinia-induced apoptosis, two inhibitors of the NF-κB pathway, IκBα superrepressor or A20, were expressed in macrophages. Macrophages expressing these proteins were infected with Yersinia pseudotuberculosis strains that secrete functionally active or inactive forms of YopJ. Apoptosis levels were substantially higher (5- to 10-fold) when active YopJ was delivered into macrophages expressing IκBα superrepressor or A20, suggesting that deactivation of the NF-κB pathway is not sufficient for rapid Yersinia-induced apoptosis. When macrophages expressing A20 were treated with specific inhibitors of MAPKs, similar levels of apoptosis (within ∼2-fold) were observed when active or inactive YopJ were delivered during infection. These results suggest that MAPK and NF-κB pathways function together to up-regulate apoptosis inhibitor gene expression in macrophages in response to Yersinia infection and that YopJ deactivates both pathways to promote rapid apoptosis. In addition, treating macrophages with a proteasome inhibitor results in higher levels of infection-induced apoptosis than can be achieved by blocking NF-κB function alone, suggesting that proapoptotic proteins are stabilized when proteasome function is blocked in macrophages.
Yersinia pseudotuberculosis uses a plasmid (pYV)-encoded type III secretion system (T3SS) to translocate a set of effectors called Yops into infected host cells. YopJ functions to induce apoptosis, and YopT, YopE, and YopH act to antagonize phagocytosis in macrophages. Because Yops do not completely block phagocytosis and Y. pseudotuberculosis can replicate in macrophages, it is important to determine if the T3SS modulates host responses to intracellular bacteria. Isogenic pYV-cured, pYV + wild-type, and yop mutant Y. pseudotuberculosis strains were allowed to infect bone marrow-derived murine macrophages at a low multiplicity of infection under conditions in which the survival of extracellular bacteria was prevented. Phagocytosis, the intracellular survival of the bacteria, and the apoptosis of the infected macrophages were analyzed. Forty percent of cell-associated wild-type bacteria were intracellular after a 20-min infection, allowing the study of the macrophage response to internalized pYV +Y. pseudotuberculosis . Interestingly, macrophages restricted survival of pYV + but not pYV-cured or ΔyopB Y. pseudotuberculosis within phagosomes: only a small fraction of the pYV + bacteria internalized replicated by 24 h. In addition, ∼20% of macrophages infected with wild-type pYV +Y. pseudotuberculosis died of apoptosis after 20 h. Analysis of yop mutants expressing catalytically inactive effectors revealed that YopJ was important for apoptosis, while a role for YopE, YopH, and YopT in modulating macrophage responses to intracellular bacteria could not be identified. Apoptosis was reduced in Toll-like receptor 4-deficient macrophages, indicating that cell death required signaling through this receptor. Treatment of macrophages harboring intracellular pYV +Y. pseudotuberculosis with chloramphenicol reduced apoptosis, indicating that the de novo bacterial protein synthesis was necessary for cell death. Our finding that the presence of a functional T3SS impacts the survival of both bacterium and host following phagocytosis of Y. pseudotuberculosis suggests new roles for the T3SS in Yersinia pathogenesis.
Murine Ly6C hi inflammatory monocytes (IMs) require CCR2 to leave the bone marrow and enter mesenteric lymph nodes (MLNs) and other organs in response to Yersinia pseudotuberculosis infection. We are investigating how IMs, which can differentiate into CD11c + dendritic cells (DCs), contribute to innate and adaptive immunity to Y. pseudotuberculosis . Previously, we obtained evidence that IMs are important for a dominant CD8 + T cell response to the epitope YopE 69–77 and host survival using intravenous infections with attenuated Y. pseudotuberculosis . Here we challenged CCR2 +/+ or CCR2 −/− mice orally with wild-type Y. pseudotuberculosis to investigate how IMs contribute to immune responses during intestinal infection. Unexpectedly, CCR2 −/− mice did not have reduced survival but retained body weight better and their MLNs cleared Y. pseudotuberculosis faster and with reduced lymphadenopathy compared to controls. Enhanced bacterial clearance in CCR2 −/− mice correlated with reduced numbers of IMs in spleens and increased numbers of neutrophils in livers. In situ imaging of MLNs and spleens from CCR2-GFP mice showed that green fluorescent protein-positive (GFP + ) IMs accumulated at the periphery of neutrophil-rich Yersinia- containing pyogranulomas. GFP + IMs colocalized with CD11c + cells and YopE 69–77 -specific CD8 + T cells in MLNs, suggesting that IM-derived DCs prime adaptive responses in Yersinia pyogranulomas. Consistently, CCR2 −/− mice had reduced numbers of splenic DCs, YopE 69–77 -specific CD8 + T cells, CD4 + T cells, and B cells in organs and lower levels of serum antibodies to Y. pseudotuberculosis antigens. Our data suggest that IMs differentiate into DCs in MLN pyogranulomas and direct adaptive responses in T cells at the expense of innate immunity during oral Y. pseudotuberculosis infection.
SeveralYersiniaspecies have been utilized as live attenuated vaccines to prime protective immunity against yersiniae and other pathogens. A type III secretion system effector known as YopJ inY. pseudotuberculosisandY. pestisand YopP inY. enterocoliticahas been shown to regulate host immune responses to liveYersiniavaccines. YopJ/P kills macrophages and dendritic cells, reduces their production of tumor necrosis factor alpha (TNF-α) and interleukin-12 (IL-12), and promotes systemic colonization in mouse models of intestinalYersiniainfection. Furthermore, YopP activity decreases antigen presentation by dendritic cells, and ayopPmutant of a liveY. enterocoliticacarrier vaccine elicited effective priming of CD8 T cells to a heterologous antigen in mice. These results suggest that YopJ/P activity suppresses both innate and adaptive immune responses to liveYersiniavaccines. Here, a sublethal intragastric mouse infection model using wild-type and catalytically inactiveyopJmutant strains ofY. pseudotuberculosiswas developed to further investigate how YopJ action impacts innate and adaptive immune responses to a live vaccine. Surprisingly, YopJ-promoted cytotoxicity and systemic colonization were associated with significant increases in neutrophils in spleens and the proinflammatory cytokines IL-18 and gamma interferon (IFN-γ) in serum samples of mice vaccinated withY. pseudotuberculosis. Secretion of IL-18 accompanied YopJ-mediated killing of macrophages infectedex vivowithY. pseudotuberculosis, suggesting a mechanism by which this effector directly increases proinflammatory cytokine levelsin vivo. Mice vaccinated with the wild-type strain or theyopJmutant produced similar levels of antibodies toY. pseudotuberculosisantigens and were equally resistant to lethal intravenous challenge withY. pestis.The findings indicate that a proinflammatory, rather than anti-inflammatory, process accompanies YopJ-promoted cytotoxicity, leading to increased systemic colonization byY. pseudotuberculosisand potentially enhancing adaptive immunity to a live vaccine.
Virulence in human-pathogenicYersiniaspecies is associated with a plasmid-encoded type III secretion system that translocates a set of Yop effector proteins into host cells. One effector, YopE, functions as a Rho GTPase-activating protein (GAP). In addition to acting as a virulence factor, YopE can function as a protective antigen. C57BL/6 mice infected with attenuatedYersinia pestisgenerate a dominant H2-Kb-restricted CD8 T cell response to an epitope in the N-terminal domain of YopE (YopE69-77), and intranasal vaccination with the YopE69-77peptide and the mucosal adjuvant cholera toxin (CT) elicits CD8 T cells that are protective against lethal pulmonary challenge withY. pestis. Because YopE69-77is conserved in manyYersiniastrains, we sought to determine if YopE is a protective antigen forYersinia pseudotuberculosisand if primary infection with this enteric pathogen elicits a CD8 T cell response to this epitope. Intranasal immunization with the YopE69-77peptide and CT elicited a CD8 T cell response that was protective against lethal intragastricY. pseudotuberculosischallenge. The YopE69-77epitope was a major antigen (∼30% of splenic CD8 T cells were specific for this peptide at the peak of the response) during primary infection withY. pseudotuberculosis, as shown by flow cytometry tetramer staining. Results of infections withY. pseudotuberculosisexpressing catalytically inactive YopE demonstrated that GAP activity is dispensable for a CD8 T cell response to YopE69-77. Determining the features of YopE that are important for this response will lead to a better understanding of how protective CD8 T cell immunity is generated againstYersiniaand other pathogens with type III secretion systems.